RxDoctor Payments Data

Thomas Way, MD

Otolaryngology · Anderson, SCNPI 1386897346

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,874 of the $3,489 with a category attached, or 82.3%. It is spread thinly across 25 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,543, 6.4 times the $240 reported in 2019.

$3,489in general payments, 2019–2025

Across 95 payments — averaging $36.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$822
  • Intersect ENT, Inc.$489
  • GSK$437
  • Acclarent, Inc$380
  • Sanofi$270
  • Integra Lifesciences Corporation$197
  • plus $894 from 19 others

What the payments were for

  • Travel & lodging$58217%
  • Food & beverage$2,87482%
  • Education$341%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,489 in reported general payments places this provider in the 75th percentile of 180 otolaryngology providers in South Carolina.

See all otolaryngology providers in South Carolina

Medicare billing

Part B allowed, 2024
$191,982
Medicare patients
541
Services billed
5,537

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab15$55,919
Mometasone Furoate45$3,565
Ipratropium Bromide142$3,200
Fluticasone Propionate254$3,014
Levocetirizine Dihydrochloride288$2,367
Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth21$2,131
Azelastine Hcl103$1,879
Esomeprazole Magnesium51$1,791
Montelukast Sodium115$1,022
Fluocinolone Acetonide Oil16$729
Famotidine64$714
Ofloxacin27$681
Dexamethasone22$567
Omeprazole54$455
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen33$321

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Anderson

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →